Tuberculosis treatment success rate in Rwanda
Rwanda: Tuberculosis treatment success rate was 90.0% in 2023. ▲ Rising
Tuberculosis treatment success rate in Rwanda, 2000–2023
Source: Global Tuberculosis Report, World Health Organization (WHO). Measured in % of new cases.
Analysis
Rwanda recorded 90.0% for tuberculosis treatment success rate in 2023. That is the highest value across all 23 years on record.
That represents a change of up 1.1% on the previous year and up 5.9% over ten years.
Over the whole period, tuberculosis treatment success rate in Rwanda peaked at 90.0% in 2023 and was at its lowest, 58.0%, in 2002.
That places Rwanda 48th out of 203 countries with data for 2023, putting it in the top quarter.
The long-run direction has been consistently rising across the 23 years of available data.
Tuberculosis treatment success rate in Rwanda, year by year
| Year | % of new cases | Change |
|---|---|---|
| 2000 | 61.0% | — |
| 2002 | 58.0% | -4.9% |
| 2003 | 67.0% | +15.5% |
| 2004 | 77.0% | +14.9% |
| 2005 | 74.0% | -3.9% |
| 2006 | 77.0% | +4.1% |
| 2007 | 80.0% | +3.9% |
| 2008 | 82.0% | +2.5% |
| 2009 | 79.0% | -3.7% |
| 2010 | 82.0% | +3.8% |
| 2011 | 84.0% | +2.4% |
| 2012 | 84.0% | +0.0% |
| 2013 | 85.0% | +1.2% |
| 2014 | 86.0% | +1.2% |
| 2015 | 87.0% | +1.2% |
| 2016 | 86.0% | -1.1% |
| 2017 | 86.0% | +0.0% |
| 2018 | 86.0% | +0.0% |
| 2019 | 87.0% | +1.2% |
| 2020 | 89.0% | +2.3% |
| 2021 | 87.0% | -2.2% |
| 2022 | 89.0% | +2.3% |
| 2023 | 90.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 72.8% | 58.0% | 82.0% | 9 |
| 2010s | 85.3% | 82.0% | 87.0% | 10 |
| 2020s | 88.8% | 87.0% | 90.0% | 4 |
Countries ranked near Rwanda
More health data for Rwanda
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.891 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 860.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,738 deaths (2100)
- Population ages 15-19, male, annual growth rate 0.1694 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0546 units per person (2025)
- Population ages 20-24, female, annual growth rate 4.71 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0497 units per person (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Rwanda?
- Tuberculosis treatment success rate in Rwanda was 90.0% in 2023, according to Global Tuberculosis Report, World Health Organization (WHO).
- What is the highest tuberculosis treatment success rate recorded in Rwanda?
- The highest recorded value was 90.0% in 2023.
- What is the lowest tuberculosis treatment success rate recorded in Rwanda?
- The lowest recorded value was 58.0% in 2002.
- How does Rwanda rank for tuberculosis treatment success rate?
- Rwanda ranks 48th out of 203 countries with data for 2023.
- Is tuberculosis treatment success rate rising or falling in Rwanda?
- Over the last ten years it is up 5.9%. The long-run trend across the full record is rising.
- Where does this Rwanda data come from?
- The figures come from Global Tuberculosis Report, World Health Organization (WHO), published as part of Tuberculosis treatment success rate (% of new cases). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).